Document 0907 DOCN M94A0907 TI Natural history of HIV-1 infected patients in Japan. Study Group of the Ministry of Health and Welfare for the Prevention and Treatment of HIV Infections. DT 9412 AU Mimaya J; Meguro T; Tatsunami S; Fujimura Y; Takamatsu J; Fukutake K; Yanagawa H; Shizuoka Children's Hospital, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(2):253 (abstract no. PC0374). Unique Identifier : AIDSLINE ICA10/94371668 AB OBJECTIVE: The Natural History committee has performed a follow-up over time and an analysis of the clinical course and laboratory data of HIV carriers. MATERIALS AND METHODS: The study subjects were HIV carriers and hemophiliacs who were outpatients in hospitals affiliated with members of the study group. As of 1988, 1,081 HIV-Ab positive cases and 1,146 negative cases had been registered. Clinical symptoms and laboratory findings were analyzed twice each year between 1985 and 1993. RESULTS AND CONCLUSIONS: 1) The CD4 counts in the HIV-Ab positive group have continued to decrease in an approximately linear manner since 1985. The overall mean decrease is 30 cells/microliter/y. Immunoglobulins tended to increase in the HIV infected group. 2) The stages of CDCIII+IV were found in 3-5% of the registered carriers in 1985. This figure has risen to 27% in 1993. 3) The cumulative AIDS incidence in the 10 years since the infection was calculated as 18%. 4) The P24 antigen positive rate was 20% in the cases tested. HIV-Ab positive cases were all positive for provirus DNA. Silent infection cases were not found. Serum HIV-RNA was detected by RT-PCR in all of the HIV-Ab positive cases. 5) In a comparison between the CDCII and IV groups, the isolation rate in the CDCIV group was significantly higher than that in the CDCII group. DE Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY Carrier State/*IMMUNOLOGY Hemophilia/COMPLICATIONS Human HIV Core Protein p24/ANALYSIS HIV Infections/*IMMUNOLOGY HIV Seropositivity Japan/EPIDEMIOLOGY Leukocyte Count T4 Lymphocytes/IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).